Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo

Mol Ther. 2007 Feb;15(2):361-8. doi: 10.1038/sj.mt.6300017.

Abstract

Although the majority of current gene transfer techniques have focused on increasing the ability of the DNA to enter the cell, it is possible that changing the proliferative and migratory state of cells will influence the cells ability to take up and express plasmid DNA. This study was designed to test the hypothesis that growth factors (basic fibroblast growth factor (bFGF) and hepatocyte growth factor/scatter factor (HGF/SF)) used to alter the proliferative and migratory state of cells can alter plasmid DNA uptake and expression. In vitro studies indicate that enhancing cell proliferation with growth factor exposure enhances plasmid DNA uptake and expression. Furthermore, dual localized delivery of bFGF and plasmid DNA in vivo increases the expression, 3-6 times over control, as compared to plasmid delivery alone. Dual delivery of a factor promoting cell proliferation and a plasmid led to a further increase in the expression of the plasmid encoding bone morphogenetic protein-2 in a rat cranial defect by specific cell populations. The results of these studies suggest that increasing the proliferative state of target cell populations can enhance non-viral gene transfer.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Bone Morphogenetic Proteins / genetics
  • Bone Morphogenetic Proteins / metabolism
  • Cell Movement / drug effects*
  • Cell Movement / genetics
  • Cell Proliferation / drug effects*
  • Fibroblast Growth Factor 2 / pharmacology*
  • Gene Expression / drug effects
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • Hepatocyte Growth Factor / pharmacology*
  • Male
  • Mice
  • NIH 3T3 Cells
  • Plasmids / genetics
  • Rats
  • Rats, Inbred Lew
  • Skull Fractures / genetics
  • Skull Fractures / pathology
  • Skull Fractures / therapy
  • Transfection

Substances

  • Bone Morphogenetic Proteins
  • Fibroblast Growth Factor 2
  • Green Fluorescent Proteins
  • Hepatocyte Growth Factor